VT
AZN icon

Vise Technologies’s AstraZeneca AZN Stock Holding History

Vise Technologies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
+14,219
New +$2.67M 0.03% 445
2026
Q1 		– Sell
-28,248
Closed -$5.19M – 1450
2025
Q4 		$5.19M Buy
28,248
+13,350
+90% +$2.34M 0.1% 165
2025
Q3 		$2.29M Buy
14,898
+74
+0.5% +$11.2K 0.09% 230
2025
Q2 		$2.07M Buy
+14,824
New +$2.08M 0.09% 248
2024
Q4 		$1.44M Buy
10,991
+219
+2% +$30.7K 0.12% 179
2024
Q3 		$1.68M Buy
10,772
+2,163
+25% +$349K 0.21% 99
2024
Q2 		$1.34M Buy
8,609
+1,688
+24% +$254K 0.24% 93
2024
Q1 		$938K Buy
6,921
+471
+7% +$62.4K 0.18% 119
2023
Q4 		$869K Buy
6,450
+120
+2% +$15.6K 0.19% 123
2023
Q3 		$857K Sell
6,330
-985
-13% -$135K 0.21% 115
2023
Q2 		$1.05M Buy
7,315
+965
+15% +$142K 0.25% 92
2023
Q1 		$881K Buy
6,350
+705
+12% +$94.9K 0.23% 101
2022
Q4 		$765K Buy
5,645
+714
+14% +$89.5K 0.24% 104
2022
Q3 		$541K Buy
4,931
+245
+5% +$31.1K 0.2% 114
2022
Q2 		$619K Buy
4,686
+2,173
+86% +$285K 0.24% 103
2022
Q1 		$333K Buy
+2,513
New +$301K 0.13% 156

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vise Technologies's AZN Position: Q2 2026 in Review

Vise Technologies opened a new position in AstraZeneca (AZN) in Q2 2026: 14,219 shares worth $2.7M. The stake represents 0.03% of the portfolio and ranks #445 among its holdings. This is a return to the name: Vise Technologies previously reported a position in AZN as recently as Q4 2025.

Vise Technologies first reported a position in AZN in Q1 2022 and has held it in 16 quarters since. The position peaked at $5.19M in Q4 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vise Technologies held 14,219 shares of AstraZeneca worth $2.7M as of Q2 2026.
  • AstraZeneca was a new Vise Technologies position in Q2 2026.
  • AstraZeneca made up 0.03% of Vise Technologies's portfolio in Q2 2026, its #445 holding.
  • Vise Technologies first reported a position in AstraZeneca in Q1 2022 and has held it in 16 quarters since.
  • Vise Technologies's AstraZeneca position peaked at $5.19M in Q4 2025.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.